Cypre's blog to discuss the latest movements in science.
Charles River’s Chief Scientific Officer, Ian Waddell, PhD, sat down with Elizabeth Anderson, PhD, CRL’s Scientific Director of Oncology in a Vital Science™ Podcast hosted by Gina Mullane, Chief Marketing Officer, called “In Vitro 3D Models: A Blueprint for Drug Development”.
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
